Company Surmodics, Inc.

Equities

SRDX

US8688731004

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
26.17 USD +0.38% Intraday chart for Surmodics, Inc. -0.83% -28.01%

Business Summary

Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company's segments include Medical Device and IVD. The Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral, coronary and structural heart. It manufactures vascular intervention medical devices, including drug-coated balloons, and radial access balloon catheters and guide sheaths. The IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.

Number of employees: 376

Sales per Business

USD in Million2022Weight2023Weight Delta
Medical Device
79.8 %
72 72.4 % 106 79.8 % +46.13%
In Vitro Diagnostics
20.2 %
28 27.6 % 27 20.2 % -2.76%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
82.0 %
74 74.0 % 109 82.0 % +46.99%
Foreign
18.0 %
26 26.0 % 24 18.0 % -8.17%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 10-12-26
Director of Finance/CFO 57 07-01-31
Corporate Officer/Principal 55 18-10-31
Comptroller/Controller/Auditor 43 17-02-28
Human Resources Officer 59 10-03-07
General Counsel 61 20-05-12
Corporate Officer/Principal 60 01-06-30

Members of the board

Members of the board TitleAgeSince
Director/Board Member 77 14-02-16
Chairman 70 08-01-28
Director/Board Member 68 01-12-31
Director/Board Member 80 11-01-04
Chief Executive Officer 61 10-12-26
Director/Board Member 61 17-04-11

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 14,236,000 13,702,309 ( 96.25 %) 0 96.25 %

Shareholders

NameEquities%Valuation
Trigran Investments, Inc.
16.57 %
2,358,300 16.57 % 69 M $
Morgan Stanley Investment Management, Inc.
8.723 %
1,241,793 8.723 % 36 M $
BlackRock Advisors LLC
7.324 %
1,042,670 7.324 % 31 M $
Vanguard Fiduciary Trust Co.
6.036 %
859,287 6.036 % 25 M $
Soleus Capital Management LP
5.421 %
771,700 5.421 % 23 M $
Millennium Management LLC
4.717 %
671,551 4.717 % 20 M $
Disciplined Growth Investors, Inc.
4.319 %
614,891 4.319 % 18 M $
Renaissance Technologies LLC
4.103 %
584,138 4.103 % 17 M $
Royce & Associates LP
2.953 %
420,412 2.953 % 12 M $
Segall Bryant & Hamill LLC
2.839 %
404,170 2.839 % 12 M $

Company contact information

Surmodics, Inc.

9924 West 74th Street

55344-3523, Eden Prairie

+952 500 7000

http://www.surmodics.com
address Surmodics, Inc.(SRDX)
  1. Stock Market
  2. Equities
  3. SRDX Stock
  4. Company Surmodics, Inc.